Recursion Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RXRX and other ETFs, options, and stocks.About RXRX
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives.
CEONajat Khan
CEONajat Khan
Employees—
Employees—
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded2013
Founded2013
Employees—
Employees—
RXRX Key Statistics
Market cap2.45B
Market cap2.45B
Price-Earnings ratio-2.59
Price-Earnings ratio-2.59
Dividend yield—
Dividend yield—
Average volume19.96M
Average volume19.96M
High today$4.68
High today$4.68
Low today$4.62
Low today$4.62
Open price$4.88
Open price$4.88
Volume500.76K
Volume500.76K
52 Week high$12.36
52 Week high$12.36
52 Week low$3.79
52 Week low$3.79
Stock Snapshot
As of today, Recursion Pharmaceuticals(RXRX) shares are valued at $4.66. The company's market cap stands at 2.45B, with a P/E ratio of -2.59.
On 2026-01-14, Recursion Pharmaceuticals(RXRX) stock traded between a low of $4.62 and a high of $4.68. Shares are currently priced at $4.66, which is +0.9% above the low and -0.4% below the high.
Recursion Pharmaceuticals(RXRX) shares are trading with a volume of 500.76K, against a daily average of 19.96M.
In the last year, Recursion Pharmaceuticals(RXRX) shares hit a 52-week high of $12.36 and a 52-week low of $3.79.
In the last year, Recursion Pharmaceuticals(RXRX) shares hit a 52-week high of $12.36 and a 52-week low of $3.79.
Analyst ratings
63%
of 8 ratingsBuy
37.5%
Hold
62.5%
Sell
0%
People also own
Based on the portfolios of people who own RXRX. This list is generated using Robinhood data, and it’s not a recommendation.